⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TLX News
Telix Pharmaceuticals Limited American Depositary Shares
TLX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Telix Pharmaceuticals Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
prnewswire.com
TLX
TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - TLX
prnewswire.com
TLX
Pomerantz LLP Advises Shareholders of Class Action Filing Against Telix Pharmaceuticals Limited – TLX
accessnewswire.com
TLX
TLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Telix Pharmaceuticals Limited Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
TLX
Pomerantz LLP Advises Shareholders of Class Action Against Telix Pharmaceuticals Limited – TLX
accessnewswire.com
TLX
TLX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Telix Pharmaceuticals Limited Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
TLX
Law Offices of Howard G. Smith Encourages Telix Pharmaceuticals Limited (TLX) Shareholders To Inquire About Securities Fraud Class Action
businesswire.com
TLX
Berger Montague PC Investigating Claims on Behalf of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) After Class Action Filing
prnewswire.com
TLX
Pomerantz LLP Advises of Securities Class Action Involving Telix Pharmaceuticals Limited – TLX
accessnewswire.com
TLX
TLX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Telix Pharmaceuticals Limited Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
TLX